GLYCIDALDEHYDE. 1. Exposure Data

Similar documents
DIBROMOACETONITRILE. 1. Exposure Data

DICHLOROACETONITRILE. 1. Exposure Data

METHYL IODIDE. 1. Exposure Data

AZIRIDINE. 1. Exposure Data

1,3-PROPANE SULTONE. 1. Exposure Data

DIMETHYLCARBAMOYL CHLORIDE. 1. Exposure Data

1,4-BENZOQUINONE (para-quinone) 1. Exposure Data

METHYL ACRYLATE. 1. Exposure Data

N,N -DIETHYLTHIOUREA. 1. Exposure Data. 1.1 Chemical and physical data Nomenclature

MELAMINE. 1. Exposure Data

(Z)-1-Chloro-2,3,3,3-tetrafluoropropene (2017)

HC RED NO Exposure Data H2N~NH-CH2-CH2-0H N02. (d) Solubilty: Soluble in water (0.28% w/w), ethanol and acetone

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

Table 4.5 Genetic and related effects of DDT in non-human mammals in vitro

H 2 C CH 2 CH 2 CH 2 O 2 S O C 4 H 8 O 3 S. Classification/MAK value: see Section III A2) MAK List 1985 Classification/MAK value dates from: 1986

DISCUSSION GROUP 3. Mechanism of carcinogenicity. EFSA Scientific Colloquium on Acrylamide carcinogenicity, 22/23 May

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

NITRILOTRIACETIC ACID AND ITS SALTS. 1. Exposure Data

IMPURITIES: GUIDELINE FOR RESIDUAL SOLVENTS PDE FOR CUMENE

HYDROGEN PEROXIDE HUMAN HEALTH EFFECTS. CAS No.: EINECS No.: REPORT VERSION: Draft of 24 April 2001

ALLYL CHLORIDE. 1. Exposure Data

To: Recipients of JACC 42. HV/mls/JACC 42 corrigendum Brussels, 15 December 2004

ENVIRONMENTAL REGULATIONS AND STANDARD SETTING Health Based Standards: Oncology - Luc Hens

FULL PRESCRIBING INFORMATION: CONTENTS*

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

5.15 HEXYTHIAZOX (176)

formic acid ethyl ester

3-MCPD and glycidol and their esters

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

MATERIAL SAFETY DATA SHEET

Chemical Name: 4H-Pyrano[3,2-g]quinoline-2,8-dicarboxylic acid, 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-, disodium salt.

Human Health Classification: General Considerations and Overview

Dichlorvos DICHLORVOS (025)


ETHYL ACRYLATE. 1. Exposure Data

OPINION of the French Agency for Environmental and Occupational Health Safety

CONTENTS NOTE TO THE READER...1 LIST OF PARTICIPANTS...3

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

SECTION 1 CHEMICAL PRODUCT AND COMPANY IDENTIFICATION COMPOSITION, INFORMATION ON INGREDIENTS

MATERIAL SAFETY DATA SHEET

VICH GL23: Studies to evaluate the safety of residues of veterinary drugs in human food: genotoxicity testing

MATERIAL SAFETY DATA SHEET

5. Summary of Data Reported and Evaluation

5.17 PENTHIOPYRAD (253)

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

PRODUCT INFORMATION WARTEC SOLUTION

Summary of Toxicity Studies on Imazapyr

CoCAM 2, April 2012 INITIAL TARGETED ASSESSMENT PROFILE

Read-across illustrative example

5.24 TRIAZOLE FUNGICIDE METABOLITES

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

2-Amino-4-nitrophenol (cas ) MSDS

International Agency for Research on Cancer (IARC) - Summaries & Evaluations

Genotoxicity Testing Strategies: application of the EFSA SC opinion to different legal frameworks in the food and feed area

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

Galactitol,1,2:5,6-dianhydro- (cas ) MSDS

5.36 THIOPHANATE-METHYL (077)

Antimicrobial AlphaSan Test Report Summary Table 08/21/01

TRIS(2,3-DIBROMOPROPYL) PHOSPHATE. 1. Exposure Data

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

A Weight of Evidence Approach to Cancer Assessment. Alan R Boobis Imperial College London

Part 2. Chemical and physical aspects

MATERIAL SAFETY DATA SHEET

Opinion of the Scientific Committee on Food on an additional list of monomers and additives for food contact materials (adopted the 18 September 1998)

EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL

TOXICOLOGICAL EVALUATIONS

Risk Assessment Report on Vinyl acetate. Human Health Part. CAS No.: EINECS No.:

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

MATERIAL SAFETY DATA SHEET

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

ALLYL ISOTHIOCYANATE. 1. Exposure Data

Section 5.3: Preclinical safety data

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

A review of human carcinogens -Part F: Chemical agents and related occupations

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

Risk Assessment Report on. Bis(hydroxylammonium)sulfate. CAS No.: EINECS no.:

Dithianon DITHIANON (180)

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL

MATERIAL SAFETY DATA SHEET

Nations, All rights reserved ANNEX 8 AN EXAMPLE OF CLASSIFICATION IN THE GLOBALLY HARMONIZED SYSTEM

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE

Risk Assessment Report on Tris (nonylphenyl)phosphite (TNPP)

Opinion of the Scientific Panel on food additives, flavourings, processing aids and materials in contact with food (AFC) on a request related to

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

ANNEX 8 AN EXAMPLE OF CLASSIFICATION IN THE

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

Committee for Risk Assessment RAC. Opinion proposing harmonised classification and labelling at EU level of. acetaldehyde; ethanal

BENZYL ACETATE. 1. Exposure Data

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

Summary of Toxicological Studies on Acrinathrin

Captan (Pesticides) Summary. Risk assessment report. Food Safety Commission of Japan. Conclusion in Brief

PRODUCT INFORMATION H 2

Standard (WES) Review

CVMP assessment report regarding the request for an opinion under Article 30(3) of Regulation (EC) No. 726/2004

EPICHLOROHYDRIN. 1. Exposure Data

INTERNATIONAL CONCIL FOR HARMONISATION OF TECHNICAL REQUIREMENTS FOR PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED GUIDELINE Q3D(R1)

MATERIAL SAFETY DATA SHEET

Transcription:

GLYCIDALDEHYDE Data were last reviewed in IARC (1976) and the compound was classified in IARC Monographs Supplement 7 (1987). 1. Exposure Data 1.1 Chemical and physical data 1.1.1 Nomenclature Chem. Abstr. Serv. Reg. No.: 765-34-4 Systematic name: Oxirane-carboxaldehyde 1.1.2 Structural and molecular formulae and relative molecular mass CH 2 CH CHO C 3 H 4 O 2 Relative molecular mass: 72.1 1.1.3 Physical properties (for details, see IARC, 1976) (a) Boiling-point: 112 113 C (b) Conversion factor: mg/m 3 = 2.95 ppm O 1.2 Production and use Glycidaldehyde has been used as a cross-linking agent for the finishing of wool, for the oil tanning and fat liquoring of leather and surgical sutures (IARC, 1976). 2. Studies of Cancer in Humans 1459

1460 IARC MONOGRAPHS VOLUME 71 3. Studies of Cancer in Experimental Animals Glycidaldehyde was tested for carcinogenicity in mice by skin application and by subcutaneous injection and in rats by subcutaneous injection. It produced malignant tumours at the site of application in both species (IARC, 1976). 4. Other Data Relevant to an Evaluation of Carcinogenicity and its Mechanisms 4.1 Absorption, distribution, metabolism and excretion 4.2 Toxic effects 4.2.1 Humans Glycidaldehyde produces skin irritation and sensitization (IARC, 1976). 4.2.2 Experimental systems Repeated inhalation of glycidaldehyde by rats resulted in a reduction in nucleated marrow cells and focal necrosis of liver and kidney. Repeated intravenous injections into rabbits lowered the leukocyte count and the proportion of polymorphonuclear cells. It is also irritating to the skin and mucous membranes (IARC, 1976). The carcinogenicity and genotoxicity of glycidaldehyde have been reviewed (Feron et al., 1991). 4.3 Reproductive and developmental effects 4.4 Genetic and related effects The genotoxicity of glycidaldehyde has been reviewed (Feron et al., 1991). 4.4.1 Humans 4.4.2 Experimental systems (see Table 1 for references) Glycidaldehyde induces mutations in bacteriophage T4, bacteria, yeast and sex-linked recessive lethal mutations in Drosophila melanogaster, but not hprt locus mutations in mouse lymphoma L5178Y. DNA adducts can be found in vitro using calf thymus DNA and in vivo in skin cells of mice treated topically with glycidaldehyde. The main adduct, in this case, has been identified as a cyclic adduct of deoxyadenosine, namely, 3-β-Ddeoxyribofuranosyl-7-(hydroxymethyl)-3H-imidazo[2,1-i]purine-3 -monophosphate. The

Table 1. Genetic and related effects of glycidaldehyde Test system Result a Dose (LED or HID) b Reference Without exogenous metabolic system With exogenous metabolic system SA0, Salmonella typhimurium TA100, reverse mutation + + 5 Wade et al. (1979) SA9, Salmonella typhimurium TA98, reverse mutation 100 Wade et al. (1979) ECF, Bacteriophage T4-infected Escherichia coli, forward mutation + NT 3400 Corbet et al. (1970) KPF, Klebsiella pneumoniae, forward mutation + NT 1.4 Knaap et al. (1982) SCR, Saccharomyces cerevisiae S211, reverse mutation NT 11000 Izard (1973) SCR, Saccharomyces cerevisiae S138, reverse mutation NT 11000 Izard (1973) DMX, Drosophila melanogaster germ cell, sex-linked recessive lethal + 1800 inj Knaap et al. (1982) mutations G5T, Gene mutation, mouse lymphoma L5178Y cells, hprt locus NT 7.2 Knaap et al. (1982) in vitro TCS, Cell transformation, Syrian hamster embryo cells in vitro (+) NT 1 Pienta et al. (1977) BID, Binding (covalent) to calf thymus DNA in vitro + 600 Van Duuren & Loewengart (1977) BID, Binding (covalent) to calf thymus DNA in vitro + NT 685 Steiner et al. (1992) BVD, Binding (covalent) to DNA, male C3H mice in vivo + 2 mg/mouse skin-painting Steiner et al. (1992) a +, positive; (+), weak positive;, negative; NT, not tested b LED, lowest effective dose; HID, highest ineffective dose; in-vitro tests, μg/ml; in-vivo tests, mg/kg bw/day; inj, injection GLYCIDALDEHYDE 1461

1462 IARC MONOGRAPHS VOLUME 71 frequency of this adduct was 1 adduct per 6.4 10 4 nucleotides after a 2-mg application and 1 adduct per 7.6 10 3 nucleotides after a 10-mg skin-painting (Steiner et al., 1992). Glycidaldehyde gave a marginally positive result of uncertain significance for the morphological transformation of Syrian hamster embryo cells in vitro. 5. Evaluation No epidemiological data relevant to the carcinogenicity of glycidaldehyde were available. There is sufficient evidence in experimental animals for the carcinogenicity of glycidaldehyde. Overall evaluation Glycidaldehyde is possibly carcinogenic to humans (Group 2B). 6. References Corbett, T.H., Heidelberger, C. & Dove, W.F. (1970) Determination of the mutagenic activity to bacteriophage T4 of carcinogenic and noncarcinogenic compounds. Mol. Pharmacol., 6, 667 679 Feron, V.J., Til, H.P., de Vrijer, F., Woutersen, R.A., Cassee, F.R. & van Bladeren, P.J. (1991) Aldehydes: occurrence, carcinogenic potential, mechanism of action and risk assessment. Mutat. Res., 259, 363 385 IARC (1976) IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man, Vol. 11, Cadmium, Nickel, Some Epoxides, Miscellaneous Industrial Chemicals and General Considerations on Volatile Anaesthetics, Lyon, pp. 175 181 IARC (1987) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs Volumes 1 to 42, Lyon, p. 64 Izard, C. (1973) Studies on the mutagenic effects of acrolein and two of its epoxides: the glycidol and the glycidal, on Saccharomyces cerevisiae. C. R. Acad. Sci. Paris, 276, 3037 3041 (in French) Knaap, A.G.A.C., Voogd, C.E. & Kramers, P.G.N. (1982) Comparison of the mutagenic potency of 2-chloroethanol, 2-bromoethanol, 1,2-epoxybutane, epichlorohydrin and glycidaldehyde in Klebsiella pneumoniae, Drosophila melanogaster and L5178Y mouse lymphoma cells. Mutat. Res., 101, 199 208 McCann, J., Choi, E., Yamasaki, E. & Ames, B.N. (1975) Detection of carcinogens as mutagens in the Salmonella/microsome test. Assay of 300 chemicals. Proc. natl Acad. Sci. USA, 72, 5135 5139

GLYCIDALDEHYDE 1463 Pienta, R.J., Poiley, J.A. & Lebherz, W., III (1977) Morphological transformation of early passage golden Syrian hamster embryo cells derived from cryopreserved primary cultures as a reliable in vitro bioassay for identifying diverse carcinogens. Int. J. Cancer, 19, 642 655 Steiner, S., Crane, A.E. & Watson, W.P. (1992) Molecular dosimetry of DNA adducts in C3H mice treated with glycidaldehyde. Carcinogenesis, 13, 119 124 Van Duuren, B.L. & Loewengart, G. (1977) Reaction of DNA with glycidaldehyde. J. biol. Chem., 252, 5370 5371 Wade, M.J., Moyer, J.W. & Hine, C.H. (1979) Mutagenic action of a series of epoxides. Mutat. Res., 66, 367 371